GLUE Monte Rosa Therapeutics, Inc. logo

GLUE Monte Rosa Therapeutics, Inc.

Healthcare
$18.81-0.37%ClosedMarket Cap: $1.22B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

166

13F Shares

64,466,399

Ownership %

78.2%

New Positions

49

Increased Positions

102

Closed Positions

17

Reduced Positions

39

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBCVirtus Biotech Clinical Trials ETF16,7180.79%
PTHInvesco Dorsey Wright Healthcare Momentum ETF50,0960.69%
XBI1,966,7310.44%
DWASInvesco Dorsey Wright SmallCap Momentum ETF92,6890.42%
LABUDirexion Daily S&P Biotech Bull 3X ETF98,4350.31%
FSMLFranklin Small Cap Enhanced ETF20,8390.30%
IWCiShares Micro-Cap ETF152,6740.20%
AVUVX155,8020.20%
IJE152,6740.20%
ASQCX19,6450.20%
AVUVAvantis U.S. Small Cap Value ETF2,296,7310.15%
USVM124,6360.14%
JPSEJPMorgan Diversified Return U.S. Small Cap Equity ETF36,1860.11%
VFMO83,4840.11%
AVSCAvantis U.S. Small Cap Equity ETF139,5390.09%
TMSLT. Rowe Price Small-Mid Cap ETF85,5860.09%
IWNiShares Russell 2000 Value ETF518,0370.07%
IBBiShares Biotechnology ETF346,4300.07%
NAJ518,0370.07%
VTWV34,1030.05%